7-Chloro-1-methyl-1H-pyrazolo[4,3-d]pyrimidine, 95.0%, 1g

2-(3-aminopiperidin-1-yl)ethan-1-ol dihydrochloride, 96%, 250mg

3-(3-methyl-1,2,4-oxadiazol-5-yl)-4,7-dihydro-5H-thieno[2,3-c]pyran-2-amine, 95.0%, 500mg

3-[4-(propan-2-yl)phenyl]butanoic acid, 95+%, 500mg

(2-Amino-6-nitrophenyl)methanol, 95.0%, 1g

1-Fluoronaphthalene, 99.0%, 500g

3-Bromo-6-nitroquinoline, 95.0%, 250mg

tert-Butyl 7-amino-3,4-dihydroquinoline-1(2H)-carboxylate, 95.0%, 5g

Nalpha-(tert-Butoxycarbonyl)-Nomega-(p-toluenesulfonyl)-L-arginine>95.0%(HPLC)(T)5g

Imidazo[1,2-b]pyridazin-3-amine, 95.0%, 1g

N-(4-bromo-3-methylphenyl)propanamide, 95.0%, 1g

2-Formyl-5-isopropylphenylboronic acid, 98%, 1g

Balance à plateforme série IFB Modèles non certifiés, 5 g, 150000 g, IFB 100K-3